AuntMinnie

MARCH 26, 2024

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Since 2013 we've had several more radiopharmaceutical therapies get FDA approval. Since the U.S.

Nuclear Medicine 122

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 122

AuntMinnie

JUNE 20, 2024

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Since 2013 we've had several more radiopharmaceutical therapies get FDA approval. Since the U.S.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 52

Imaging Technology

JUNE 10, 2024

As SNMMI president-elect, I plan to focus on bringing and integrating radiopharmaceutical theranostics into the clinic to benefit as many patients as possible. SNMMI introduced a new slate of officers during its 2024 Annual Meeting, held June 8-11 in Toronto. “As

Nuclear Medicine 59

Nuclear Medicine Radiopharmaceuticals Hospital Health Science 59

AuntMinnie

APRIL 4, 2024

A decade ago, only a few radiopharmaceutical agents were used to help treat cancer patients. Vroman is a dual board-certified nuclear radiologist and associate professor at the University of Texas (UT) Health Science Center in San Antonio. However, few freestanding theranostics centers exist today.

Nuclear Medicine 87

Nuclear Medicine Radiation Oncology Nursing Radiation 87